Author: Rahi, Mandeep Singh; Jindal, Vishal; Reyes, Sandra-Patrucco; Gunasekaran, Kulothungan; Gupta, Ruby; Jaiyesimi, Ishmael
Title: Hematologic disorders associated with COVID-19: a review Cord-id: 1fg77ptl Document date: 2021_1_7
ID: 1fg77ptl
Snippet: Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2. Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem abnormalities. Hematologic manifestations constitute a significant area of concern. Severe acute respiratory syndrome coronavirus 2 infects monocytes and endothelial cells leading to a complex downstream cascade, cytokine storm, and eventual intravascular thrombosis. Coronavirus disease 2019 causes lymphopenia, neu
Document: Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2. Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem abnormalities. Hematologic manifestations constitute a significant area of concern. Severe acute respiratory syndrome coronavirus 2 infects monocytes and endothelial cells leading to a complex downstream cascade, cytokine storm, and eventual intravascular thrombosis. Coronavirus disease 2019 causes lymphopenia, neutrophilia, and thrombocytopenia. Prophylactic anticoagulation is vital in patients with coronavirus disease 2019, as its effect on the coagulation system is associated with significant morbidity and mortality. The disease can cause both arterial and venous thromboses, especially pulmonary embolism and pulmonary microthrombi. A high index of suspicion is indispensable in recognizing these complications, and timely institution of therapeutic anticoagulation is vital in treating them. Virus-induced disseminated intravascular coagulation is uncommon but shares some similarities to sepsis-induced disseminated intravascular coagulation. Marked elevations in hematologic biomarkers such as lactate dehydrogenase, D-dimer, ferritin, and C-reactive protein are associated with worse outcomes. Understanding the pathophysiology and recognizing factors associated with poor prognosis are crucial in improving patient outcomes with coronavirus disease 2019.
Search related documents:
Co phrase search for related documents- activation recruitment and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- activation recruitment and acute coronary syndrome: 1
- activation recruitment and acute phase: 1, 2, 3
- activation recruitment and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- activation recruitment and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- active bleeding and acute ards respiratory distress syndrome: 1, 2
- active bleeding and acute coronary syndrome: 1
- active bleeding and acute kidney injury: 1, 2
- active bleeding and acute pancreatitis: 1
- active bleeding and acute respiratory syndrome: 1, 2
- active pharmaceutical and acute ards respiratory distress syndrome: 1
- active pharmaceutical and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- active pharmaceutical and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date